The annual high-tech pharmaceutical product imports to Finland have shown substantial growth from 2013 to 2023, with imports reaching 771.4 Million Euros in 2023. Despite experiencing fluctuations, such as a sharp decline in 2016 (-9.91%) and 2017 (-5.19%), the imports managed to steadily increase from 2018 onward. The last two years indicated modest but positive growth: 1.93% in 2022 and 1.72% in 2023. The compound annual growth rate (CAGR) for the last five years stands at 2.96%.

Forecasted data for the next five years predict a continued upward trend, with the imports expected to reach 820.47 Million Euros by 2028. However, the forecasted five-year CAGR drops to 0.93%, indicating a more gradual growth rate compared to the previous years.

Future trends to watch for include:

Potential innovations in high-tech pharmaceuticals that could spur higher import rates.
Impact of global economic conditions and supply chain disruptions on import volumes and values.
Government policies and regulations affecting pharmaceutical imports.